NOTA Laboratories, Inc.

Ann Arbor, MI · Medtech · Private

LANOR™: a light-activated nitric oxide release device for inhaled NO therapy delivery

notalabs.com →
Grants
$9.8M
16 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · S-Nitrosothiol-Based Rinse/Aerosol Solutions For Treatment/Prevention of Rhinosinusitis$232,832
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase II · S-Nitrosothiol-Based Rinse/Aerosol Solutions for Treatment/Prevention of Rhinosinusitis (Phase II)$1,504,707
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase II · S-Nitrosothiol-Based Rinse/Aerosol Solutions for Treatment/Prevention of Rhinosinusitis (Phase II)$858,200
Federal grantDepartment of Health and Human Services · Phase II · S-Nitrosothiol-Based Rinse/Aerosol Solutions for Treatment/Prevention of Rhinosinusitis (Phase II)$646,507
Federal grantDepartment of Health and Human Services · Phase I · Antimicrobial Intravascular Catheter Lock Solutions Based on Endogenous Nitric Oxide Release Agent$233,275
Federal grantDepartment of Health and Human Services · Phase I · Antimicrobial Intravascular Catheter Lock Solutions Based on Endogenous Nitric Oxide Release Agent$233,275
Federal grantDepartment of Health and Human Services · Phase I · Photochemical Generation of Gas Phase Nitric Oxide from ImmobilizedS-Nitrosothiols for Biomedical Applications$258,994
Federal grantDepartment of Health and Human Services · Phase I · Photochemical Generation of Gas Phase Nitric Oxide from ImmobilizedS-Nitrosothiols for Biomedical Applications$258,994
Federal grantDepartment of Health and Human Services · Phase I · Extended Nitric Oxide Delivery Device to Reduce/Prevent Tunneled Dialysis Catheter Infections$224,943
Federal grantDepartment of Health and Human Services · Phase II · Low Cost Electrochemical Gas Phase Nitric Oxide Generator for Biomedical Applications$207,807
Federal grantDepartment of Health and Human Services · Phase I · Extended Nitric Oxide Delivery Device to Reduce/Prevent Tunneled Dialysis Catheter Infections$224,943
Federal grantDepartment of Health and Human Services · Phase II · Low Cost Electrochemical Gas Phase Nitric Oxide Generator for Biomedical Applications$602,645
Federal grantDepartment of Health and Human Services · Phase II · Low Cost Electrochemical Gas Phase Nitric Oxide Generator for Biomedical Applications$865,106
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase II · Photochemical Generation of Gas Phase Nitric Oxide from Immobilized S-Nitrosothiols for Biomedical Applications$1,730,175
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase II · Photochemical Generation of Gas Phase Nitric Oxide from Immobilized S-Nitrosothiols for Biomedical Applications$928,479
Federal grantDepartment of Health and Human Services · Phase II · Photochemical Generation of Gas Phase Nitric Oxide from Immobilized S-Nitrosothiols for Biomedical Applications$801,696
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1125NX Prenatal Inc.—$5.8M
1126iNanoBio, Inc.—$3.3M
1127ZeoVation, Inc.—$780K
1128NOTA Laboratories, Inc.——
1129SPERRY MEDTECH INC.——
1130Carna Inc.—$3.4M
1131OLI Technologies, Inc.—$700K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 2
  • Nitric Oxide Releasing Films And Systemsapplication
  • Nitric Oxide Generating Films And Systemsapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.